JNJ
NYSE
Healthcare
Johnson & Johnson
n/a
price not loaded
Financials
Select any card to open it. The button on a card or stat shows where that number comes from.
Annual figures
Johnson & Johnson (JNJ) reported revenue of $25.3B, net income of $5.53B and diluted EPS of $2.27 in the quarter ended Jun 28, 2026. The table lists its latest fiscal years as originally reported in its SEC filings; the interactive charts show the same figures by quarter.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| Fiscal 2025ended Dec 28, 2025 | $94.2B | $26.8B | $11.04 | $19.7B |
| Fiscal 2024ended Dec 29, 2024 | $88.8B | $14.1B | $5.79 | $19.8B |
| Fiscal 2023ended Dec 31, 2023 | $93.0B | $35.2B | $13.81 | $18.2B |
| Fiscal 2022ended Jan 1, 2023 | $94.9B | $17.9B | $6.73 | $17.2B |
As originally reported. A figure a company did not report says so; nothing is estimated or filled in.